VANC Pharmaceuticals Retains Investor Relations Firm – August 23, 2018

Vancouver, BC (August 23, 2018) – Vanc Pharmaceuticals Inc. (TSX VENTURE: VANC) ( the “Company”) announced today that it has entered into a consulting agreement with Transcend Capital Inc. (“Transcend”) to develop and implement an investor relations program for the Company. Transcend, with offices in Vancouver, British Columbia, is a full-service investor relations firm that […]

VANC Announces Issuance of Shares for Services Rendered – August 9, 2018

VANCOUVER, BC, August 9, 2018 – VANC Pharmaceuticals Inc. (“VANC” or the “Company”) announces that it has issued a total of 50,458 common shares of the Company to Lampyon Canada Inc., in consideration for services rendered pursuant to the terms of a Service Agreement entered into with VANC on April 10th, 2018. The common shares […]